英为财情Investing.com - ProPhase Labs (NASDAQ: PRPH )星期三发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.350，总营收为$3.15M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$2.82M，每股收益为$-0.310.

GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the closing of its ...

ProPhase Labs, Inc. (PRPH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago. These figures ...

在充满挑战的市场环境中，ProPhase Labs, Inc. (PRPH)的股价触及52周新低，达到1.99美元。这一最新跌幅凸显了该公司正经历的艰难时期，过去一年其股价已下跌55.27%。投资者一直密切关注ProPhase Labs，因为它正在应对一系列显著影响其市场估值的不利因素。52周新低作为公司业绩和投资者情绪的关键指标，标志着该股票在过去一年中的最低交易价格。随着ProPhase ...

ProPhase Labs shares are trading lower by 50% during Friday's session. The company announced a 4.17 million share offering at ...

ProPhase Labs PRPH is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

ThinkEquity is acting as sole book-running manager for the offering.

ProPhase Labs (PRPH) announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the ...

On Friday, ProPhase Labs Inc (PRPH) stock saw a decline, ending the day at $0.78 which represents a decrease of $-0.65 or -45.45% from the prior close of $1.43. The stock opened at $0.7 and touched a ...

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare ...

Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 GARDEN CITY, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.

GARDEN CITY, NY - ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and diagnostics company, announced today its financial outlook for 2025, projecting substantial revenue and pre-tax ...